Vetr Upgrade's REGN's On Price Growth Following Positive Guidance
May 19, 2017 at 07:28 AM EDT
The Vetr crowd upgraded its rating for Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) from 1 star (Strong Sell), issued three days ago, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|